Youth Mental Health Recovery in the Family After Inpatient Stay (ReCoVer)

March 12, 2025 updated by: Amos-Silvio Erik Friedrich, University of Vienna

Reintegration, Coping, and Care of Families After Inpatient Child and Adolescent Psychiatric Treatment

The goal of this longitudinal mixed-methods study is to investigate caregiver strain, family processes and health outcomes after youth psychiatric inpatient treatment. Caregivers of youth who received inpatient treatment for mental health problems will complete a survey at three timepoints (baseline, 3- and 6- month followup) reporting on youth outcomes, caregiver well-being, and family processes. Qualitative interviews on caregivers' challenges, needs, and resources around the return to home care are conducted with a subsample (target n = 10) of participants.

The main research questions (RQs) are:

RQ 1: Do family processes contribute to youth mental health outcomes after discharge from inpatient treatment? RQ 1a: What family-level risk factors predict youth readmission to inpatient treatment? RQ 1b: Do family processes predict youth mental health trajectories over time? RQ 2: Is there a reciprocal relationship between youth mental health problems and caregiver burden? RQ 2a: Do family processes mediate the association between caregiver burden and youth mental health problems? RQ 3: How do caregivers experience their children's return to home care? RQ 3a: What challenges and needs do caregivers report? RQ 3b: What types of follow-up services do families receive and/or have access to? RQ 3c: How do caregivers cope with ongoing difficulties in the post-discharge period?

Study Overview

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

primary caregivers (parents or guardians regardless of the biological relationship to the child) of children and adolescents who received inpatient psychiatric treatment

Description

Inclusion Criteria:

  • 18 years or older
  • primary caregiver of a child or adolescent aged 7-21 years of any gender who received inpatient treatment in a psychiatric institution in Germany, Austria, or Switzerland (min. 24 h stay) within the past month (regardless of the diagnosis or the reason for the treatment, respectively)
  • lived with the child or adolescent in the same household since discharge

Exclusion Criteria:

  • another caregiver of the same child has already participated in the study
  • insufficient knowledge of German

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
caregivers
primary caregivers of youth who received inpatient psychiatric treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth mental health
Time Frame: Change from baseline (T0) to 3-month (T1) and 6-month (T2) follow-up
Caregiver-reported youth internalizing and externalizing problems (assessed using the Pediatric Symptom Checklist)
Change from baseline (T0) to 3-month (T1) and 6-month (T2) follow-up
Inpatient readmission
Time Frame: Within 6 months
Occurrence (and admission date) of inpatient mental health treatment after discharge
Within 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth health-related quality of life
Time Frame: Change from baseline (T0) to 3-month (T1) and 6-month (T2) follow-up
Quality of life related to self-esteem, school, and peer relationships (assessed using the KINDL-R)
Change from baseline (T0) to 3-month (T1) and 6-month (T2) follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martina Zemp, Professor, University of Vienna

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

March 5, 2025

First Submitted That Met QC Criteria

March 5, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 01291

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caregiver Burden

Subscribe